NCT07524933 is a NA clinical trial of Nerve Hydrodissection with 5% Dextrose in Conditions, sponsored by Antalya Training and Research Hospital.

Who is sponsoring NCT07524933?

NCT07524933 is sponsored by Antalya Training and Research Hospital.

What drugs are being tested in NCT07524933?

Interventions in NCT07524933: Nerve Hydrodissection with 5% Dextrose.

What condition does NCT07524933 study?

NCT07524933 studies Conditions.

Is NCT07524933 still recruiting?

NCT07524933 is currently active, enrolled. Last updated 13 April 2026.

Last reviewed 2026-04-13 · How we verify

NCT07524933

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of the Effectiveness of Nerve Hydrodissection With Saline Injection of 5% Dextrose in Carpal Tunnel Syndrome.

Active, enrolled NA Last updated 13 April 2026

What this trial tests

NA trial testing Nerve Hydrodissection with 5% Dextrose in Conditions in 96 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

8 January 2026

Primary endpoint
10 July 2026

10 July 2026

Quick facts

Lead sponsor	Antalya Training and Research Hospital
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	96
Start date	8 January 2026
Primary completion	10 July 2026
Estimated completion	10 July 2026
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Nerve Hydrodissection with 5% Dextrose

Conditions studied

Conditions — all drugs for Conditions →

Sponsor

Antalya Training and Research Hospital

Who can join

Adults 18 to 80, any sex, with Conditions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of the effectiveness of nerve hydrodissection with saline injection of 5% dextrose in carpal tunnel syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Antalya Training and Research Hospital trials

Trials by the same sponsor.

NCT07480811 — The Effect of the DASH Diet on Clinical and Metabolic Parameters in Children With MASLD · NA · not yet recruiting
NCT07453615 — Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children · NA · recruiting
NCT07324655 — Association Between Office Ergonomics, Work Organization, and Musculoskeletal Complaints in Medical Secretaries · recruiting
NCT07497295 — Ultrasound Assessment of Femoral Vein and Inferior Vena Cava Collapsibility to Predict Spinal Anesthesia-Induced Hypoten · recruiting
NCT07338721 — Does Ultrasound Guidance Axillary Incision Improve Sentinel Lymph Node Detection in Breast Cancer? · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07524933 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Antalya Training and Research Hospital
Last refreshed: 13 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07524933.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing